Gut Immune Balance Is as Easy as S-F-B  by Mazmanian, Sarkis K.
repertoire in the islets is not skewed and
the fact that at later stages, the disease
becomes lymph node independent.
Nonetheless, it is clear that chemokines
do play a role in tissue entry. NOD.Ccl3/
mice show reduced insulitis and are
protected from diabetes (Cameron et al.,
2000). Furthermore, islet infiltration can be
achieved by overexpression of a number
of different chemokines driven by the rat
insulin promoter even in the B6 back-
ground that is not autoimmune prone
and that does not normally develop islet
infiltration (Luther et al., 2002). It has been
suggested that these cells are not islet
specific, but it is also conceivable, as
would be suggested by the results of
Lennon et al. (2009), that they are in fact
islet-antigen specific but there are other
mechanism of tolerance that prevent
islet destruction. The model presented
by Lennon et al. will be very useful in
addressing the specific role of chemo-
kines in tissue entry of islet-antigen-
specific T cells. Additional studies are
needed to understand the sequence of
events that lead to tissue entry, retention,
and destruction.
Perhaps the most important impact of
this effort is a renewed opportunity to
determine theautoreactiveTcells involved
in T1D. Attempts to find the antigen
responsible for the break in tolerance in
diabetes have been complicated by diffi-
culties in cloning antigen-specific T cells.
ThedatapresentbyLennonetal. suggests
that analyzing the infiltrates directly, espe-
cially at early stages of disease may be
most helpful. Although most of the human
studies have been done on patients with
clinical symptoms and, therefore, at late
stages of disease, and inevitably with
peripheral blood as a source of T cells,
this work emphasizes the need to look
directly at the autoimmune target tissues.
Programs such as the JDRF-supported
nPOD project (http://www.jdrfnpod.org/)
will hopefully provide the tools needed to
tackle this problem in humans.
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Microbes appear to modulate homeostatic plasticity of T helper and T regulatory cells. In this issue of Immu-
nity, Gaboriau-Routhiau et al. (2009) now reveal that segmented filamentous bacteria uniquely coordinate the
intestinal T cell profile. The potential implications of this process to various immune functions are discussed.The human genome encodes information
for the development of all of our body’s
cells, including those of the adaptive
immunesystem.CD4+Tcells servecritical
immunologic functions and are primarily
involved in mediating resistance to
microbial infections. After their lineage
commitment in the thymus, naive CD4+ T
cells enter the periphery where they
receive environmental (extragenomic) sig-
nals that further instruct their maturation.
During responses to infectious disease,536 Immunity 31, October 16, 2009 ª2009 Emicrobial and host signals at the site of
infection provide cues to naive T cells to
induce their differentiation into various
pro- and anti-inflammatory subsets. For
example, infection by intracellular patho-
gens drive the development of T helper 1
(Th1) cells, whereas responses to extra-
cellular pathogens are predominantly of
the Th2 and Th17 cell subset (Bettelli
et al., 2006). These proinflammatory T
helper cells coordinate many aspects of
the innate and adaptive immune responselsevier Inc.to effectively clear microbial invaders.
Though teleologic design predicts that
the adaptive immune system evolved
for this purpose, uncontrolled and indis-
criminate T cell responses lead to immu-
nity destructive to the host such as
inflammatory bowel disease, autoimmune
diseases, and allergies. A primary mecha-
nism to prevent these deleterious reac-
tions is mediated by regulatory T cells
(Treg cells) (Sakaguchi et al., 2008).
Various subsets of CD4+ Treg cells control
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Previewsorgan-specific autoimmunity
and are also induced at
the site of infection pre-
sumably to dampen immune
responses after pathogen
clearance. Microbial signals
and the immune environment
they create during infection
modulate the peripheral func-
tion of T cells. Furthermore,
the proper balance of proin-
flammatory T helper cells and
anti-inflammatory Treg cells
critically affects the onset
and/or progression of nonin-
fectious immune-mediated
diseases.
Recent studies now show
that signals from nonpatho-
genic microbes help ‘‘fine-
tune’’ the homeostatic profile
of CD4+ T cells (Round and
Mazmanian,2009). Incontrast
to infections that are rela-
tively rare and opportunistic,
mammals are permanently
colonized by a diverse collec-
tion of commensal microor-
ganisms known as the micro-
biota. In particular, 100 trillion
bacteria of greater than 1,000
species harbored in the
mammalian gastrointestinal (GI) tract for
the life of the host. By virtue of the sheer
magnitude of this interkingdom interac-
tion, it is no surprise that commensal
bacteria profoundly affect the immune
profile of the host (in the absence of infec-
tion). Previous work has shown that
germ-free animals (devoid of microbial
colonization) display an imbalance in their
Th1-Th2 cell profile and have reduced
CD4+ T cell proportions (Mazmanian
et al., 2005). Colonization with a complex
microbiota or even a unique single
species of bacteria is sufficient to restore
a ‘‘normal’’ immune profile. Therefore,
‘‘normal’’ is defined not by the makeup
of the steady-state T helper cell response
as instructed by the host genome, but
more accurately by the combination of
host and microbial genetic instructions.
In addition, certain Treg cell populations
and Treg cell markers appear to be
altered in germ-free animals (Round and
Mazmanian, 2009). At least in the intes-
tine, Th17 cell development appears to
be exquisitely dependent on microbial
colonization. Several recent reports have
shown that remarkably, germ-freeanimals
have highly reduced (if not missing) gut
Th17 cells (Atarashi et al., 2008; Ivanov
et al., 2008). Because Th17 and Treg cell
development appear to be highly coordi-
nated, commensal microbes appear to
influence the T helper:Treg cell balance
through various molecular mediators
(e.g., microbial DNA, microbial ATP)
(Chow and Mazmanian, 2009). Further-
more, and perhaps most importantly, not
all commensal bacteria have a similar
ability to induce intestinal T helper cell
development. Therefore, the implications
from these studies are that defined
members of the microbiota have evolved
theuniqueability todirect specific aspects
of immune system maturation.
The report by Gaboriau-Routhiau et al.
(2009) in the current issue of Immunity
now identifies a single microbial species
that appears to have the broad ability
to coordinate gut T cell responses dur-
ing homeostatic colonization (Figure 1).
Numerous pathogenic microbes are
known to elicit Th1, Th2, or Th17 cell
responses during infections. This does
not appear to be too surpris-
ing, with the interpretation
being that proper immune
recognition of the pathogen
results in a synchronization
of the suitable T cell response
to clear an infection. This
notion is further supported
by evidence that deletion of
a specific arm of the T helper
cell response (e.g., T-bet-
deficient mice without a Th1
cell response) results in an
animal susceptible to the
particular category of path-
ogen the T helper cell
response controls (e.g., T-
bet-deficient mice are sus-
ceptible to the intracellular
pathogen Mycobacterium
tuberculosis) (Sullivan et al.,
2005). Bearing in mind the
extraordinary diversity and
complexity of the intestinal
microbiota, how can specific
microbes with discrete bio-
logical functions be identi-
fied? The approach used by
Gaboriau-Routhiau et al.
(2009) to find the ‘‘microbial
needle in the haystack’’
appears as serendipitous as
it is rigorous. Initially, transcriptome anal-
ysis showed that whereas colonization
of germ-free animals with a complex
murine microbiota induced gene expres-
sion similar to conventionally raised mice,
colonization of germ-free mice with
human fecal microbiota did not induce
the same changes. This is surprising
because the human microbiota contains
a complex consortium of microbes and
suggests a nonredundant or unique role
for particular microbial species. Further-
more, when the mouse microbiota was
cultured under laboratory conditions
and used to colonize germ-free animals,
cytokine production in the gut by the
culturable constituency appeared similar
to germ-free animals, implying the
microbe(s) of interest are unculturable.
FISH (Fluorescent in-situ hybridization)
analysis revealed that bacteria of
the Clostridium group were selectively
depleted from culturedmurine and human
bacteria. Because these microbes are
heat-resistant spore formers, heating of
the donor microbiotas retained the immu-
nomodulatory activity. On the basis of
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Figure 1. Segmented FilamentousBacteria Adhere Tightly to theGut
Epithelium and Coordinate T Cell Responses
Most commensal microorganisms reside in the gut lumen, spatially separated
from the host immune system. Gaboriau-Routhiau et al. (2009) show that
segmented filamentous bacteria (SFB) make close contacts with the mucosal
epithelium near Peyer’s patches. Colonization with SFBs (but not many other
commensal species) induces the expression of a variety of innate and adaptive
immune genes in the gut. Furthermore, germ-free animals mono-associated
with SFBs develop Th1, Th17, and Treg cell populations similarly to animals
colonized with a complex microbiota. It appears SFBs have the unique and
nonredundant capacity to influence T helper and T regulatory cell populations
in the gut.
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Previewsclues from the pioneering work of John
Cebra who demonstrated that segmented
filamentous bacteria (SFBs) have strong
immune stimulating properties (mainly
analyzing antibody responses) (Talham
et al., 1999), the authors hypothesized
that SFBs, a spore forming Clostridium
species, may be the ‘‘missing link’’ as
the specific microbe that coordinates
homeostatic intestinal T cell responses.
Globally, transcriptional profiling deter-
mined by microarray analysis revealed
a strong clustering of numerous genes
between conventional and SFB mono-
colonized mice. Immune pathways
including mucosal expression of RegIIIg,
interferon-g (IFN-g), interleukin-1b (IL-1b),
IL-10, IL-17, iNOS, and IL-12p40 were
similar between animals with a complex
microbiota and those harboring SFBs
alone. It has to be noted that the degree
of SFB colonization waned over time,
but gratifyingly, so did the amounts of
the aforementioned immune transcripts.
The lack of SFBs in the culturable micro-
biota from human and murine donors
(which did not induce immune responses)
further supported the notion that SFBs
possess a unique immunomodulating
function, whereas potentially hundreds
of other gut bacterial species do not. As
shown by scanning electron microscopy,
SFBs adhere tightly to Peyer’s patches
of the small intestine and concomitantly
induce local expression of IFN-g, IL-10,
and IL-17. Collectively, the gene expres-
sion studies performed by Gaboriau-
Routhiau et al. (2009) suggest that SFBs
are altering T cell profiles during coloniza-
tion (their effects on antibody production
and B cell activation in germinal centers
was shown a decade ago). Finally,
the authors directly analyzed cytokine
expression by specific T cell subsets in
animals colonized with a conventional
microbiota or mono-associated with
SFBs. Compared to germ-free animals,
SFB colonization increased IFN-g pro-
duction among CD4+ T cells (Th1),538 Immunity 31, October 16, 2009 ª2009 EIL-17 production among CD4+ T cells
(Th17), and the total number of CD4+
CD25+Foxp3+ Treg cells among lamina
propria lymphocytes of both the small
intestine and colon. Notably, in almost all
cases, the numbers of T helper and Treg
cells in SFB mono-colonized animals did
not approach those of mice with a
complete microbiota, suggesting that
SFBs are sufficient for these changes,
but may synergize with other organisms
to coordinate the full maturation of intes-
tinal T cell profiles. Taken together, the
findings reported by Gaboriau-Routhiau
et al. (2009) reveal that a single murine
commensal bacterium possesses the
unique capacity to induce the develop-
ment of a multifaceted adaptive immune
response in the gut.
Recent studies have demonstrated that
the microbiota can have a profound and
long-lasting effect on the development of
our immune system both inside and
outside the intestine. Gaboriau-Routhiau
et al. (2009) show that a single bacterium,
SFBs, profoundly alter the profile of both
pro- and anti-inflammatory T cells in the
gut. Numerous unsolved mysteries about
this process will make the forthcoming
investigations in this area very exciting.
For example, what bacterial molecule(s)
mediate the SFB effect? How can a single
organism coordinate such a diverse
immunological response; i.e., what cells
of the immune system (epithelial cells,
dendritic cells, macrophages, etc.) sense
and respond to SFBs? Perhaps, more
importantly, it remains to be seen what
effects (if any) this process has on host
health. Proinflammatory T helper cells
are critical in controlling microbial infec-
tions; are SFB-colonized animals better
able to fight pathogens than animals
without SFBs? Furthermore, aberrant
Th1, Th2, and Th17 cell reactions lead
to host pathologies (autoimmunity and
allergies), if not controlled by Treg cells
(Bettelli et al., 2006). Potentially, the dialog
between the host and microbe canlsevier Inc.influence the development of diseases
such as inflammatory bowel disease,
rheumatoid arthritis, multiple sclerosis,
type 1 diabetes, and asthma. Mounting
evidence suggests the hypothesis that
alterations in the gastrointestinal micro-
biota (due to recent lifestyle changes)
have disrupted microbial-mediated
mechanisms of immunological tolerance
within and outside the gut (Round and
Mazmanian, 2009). In other words, the
composition of the microbiota can affect
various immunologic diseases in humans.
It appears that the convergence between
thefieldsofmicrobiology and immunology
will reveal novel biological paradigms
about our intimate association with the
microbial world and how these associa-
tions affect our health.
REFERENCES
Atarashi, K., Nishimura, J., Shima, T., Umesaki, Y.,
Yamamoto, M., Onoue, M., Yagita, H., Ishii, N.,
Evans, R., Honda, K., and Takeda, K. (2008).
Nature 455, 808–812.
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom,
T.B., Oukka, M., Weiner, H.L., and Kuchroo, V.K.
(2006). Nature 441, 235–238.
Chow, J., and Mazmanian, S.K. (2009). Cell Host
Microbe 5, 8–12.
Gaboriau-Routhiau, V., Rakotobe, S., Le´cuyer, E.,
Mulder, I., Lan, A., Bridonneau, C., Rochet, V.,
Pisi, A., De Paepe, M., Brandi, G., et al. (2009).
Immunity 31, this issue, 677–689.
Ivanov, I.I., Frutos Rde, L., Manel, N., Yoshinaga,
K., Rifkin, D.B., Sartor, R.B., Finlay, B.B., and Litt-
man, D.R. (2008). Cell Host Microbe 4, 337–349.
Mazmanian, S.K., Liu, C.H., Tzianabos, A.O., and
Kasper, D.L. (2005). Cell 122, 107–118.
Round, J.L., and Mazmanian, S.K. (2009). Nat.
Rev. Immunol. 9, 313–323.
Sakaguchi, S., Yamaguchi, T., Nomura, T., and
Ono, M. (2008). Cell 133, 775–787.
Sullivan, B.M., Jobe, O., Lazarevic, V., Vasquez,
K., Bronson, R., Glimcher, L.H., and Kramnik, I.
(2005). J. Immunol. 175, 4593–4602.
Talham, G.L., Jiang, H.Q., Bos, N.A., and Cebra,
J.J. (1999). Infect. Immun. 67, 1992–2000.
